KULR Expands into High-Growth Robotics Market with German Bionic AI-Powered Exoskeletons for U.S. Workforce | KULR Stock News

Author's Avatar
Apr 15, 2025
Article's Main Image
  • KULR secures exclusive North American distribution rights for German Bionic's exoskeletons.
  • Strategic move positions KULR in a market projected to reach $41.5 billion by 2033.
  • Plans for domestic manufacturing to enhance scalability and support U.S. supply chain resilience.

KULR Technology Group (KULR, Financial) has announced a significant expansion into the high-growth robotics market through a strategic partnership with German Bionic, a renowned global robotics company. This collaboration will focus on the Apogee ULTRA exoskeleton technology, and KULR will hold exclusive rights for marketing and distribution in North America. This move places KULR in a market that is projected to grow to $41.5 billion by 2033.

The partnership aims to leverage KULR's advanced energy management expertise, applying it to the AI-powered robotics sector. KULR's enhanced focus on AI integration and performance improvement aligns with the growing demand for sophisticated thermal management and battery optimization required in robotics. Under the leadership of Josh Steinmann, VP of AI and Robotics, KULR plans to boost the technological capabilities of the Apogee ULTRA and localize future manufacturing within the United States.

This strategic initiative is designed to support domestic supply chain resilience and manufacturing reshoring efforts, aligning with U.S. national priorities. By bringing manufacturing to the U.S., KULR aims to reduce lead times and improve scalability, further strengthening its position in the robotics market. German Bionic's existing customer base includes major entities such as Dachser Intelligent Logistics, GXO, and Charité Hospital Berlin, offering a solid foundation for KULR's market penetration efforts.

The Apogee ULTRA exoskeleton technology offers promising returns on investment by significantly enhancing human energy output and reducing workplace injuries. These advancements are expected to drive employee satisfaction and retention while decreasing healthcare costs, providing a robust incentive for widespread adoption across various sectors such as logistics, manufacturing, and healthcare.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.